IBD: Crohn's Disease
Transition Pathway Brochure for IBD Patients
Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.
Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.
Tags: IBD
Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.
[flipbook pdf="https://cdhf.ca/wp-content/uploads/2019/10/Biosimilar-Transition-Pamphlet.pdf"]